Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

John Francis Kelly, Ph.D.

Title
Institution
Department
Address
Phone
Fax

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. R01AA026288 (KELLY, JOHN F) May 1, 2018 - Apr 30, 2023
    NIH/NIAAA
    Expanding the science on recovery mutual aid for alcohol use disorder: An investigation of SMART Recovery
    Role: Principal Investigator
  2. R21AA022693 (KELLY, JOHN F) Sep 20, 2014 - Aug 31, 2016
    NIH/NIAAA
    Characterization and evaluation of addiction recovery community centers
    Role: Principal Investigator
  3. R21MH101271 (KELLY, JOHN F) May 15, 2014 - Apr 30, 2016
    NIH/NIMH
    Testing Peer Support to Enhance Outcomes for Mood Disorders
    Role: Principal Investigator
  4. K24AA022136 (KELLY, JOHN F) Mar 1, 2014 - Feb 28, 2019
    NIH/NIAAA
    Mentoring in Patient-Oriented Addiction Research
    Role: Principal Investigator
  5. R01AA019664 (KELLY, JOHN F) Sep 5, 2011 - May 31, 2014
    NIH/NIAAA
    Development and Testing of Adolescent Twelve-Step Facilitation
    Role: Principal Investigator

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Kelly JF, Greene MC, Bergman B, Hoeppner B. Smoking cessation in the context of recovery from drug and alcohol problems: Prevalence, predictors, and cohort effects in a national U.S. sample. Drug Alcohol Depend. 2018 Dec 08; 195:6-12. PMID: 30557814.
    View in: PubMed
  2. Kelly JF, Claire Greene M. The reality of drinking and drug using dreams: A study of the prevalence, predictors, and decay with time in recovery in a national sample of U.S. adults. J Subst Abuse Treat. 2019 Jan; 96:12-17. PMID: 30466542.
    View in: PubMed
  3. Yeterian JD, Bursik K, Kelly JF. "God put weed here for us to smoke": A mixed-methods study of religion and spirituality among adolescents with cannabis use disorders. Subst Abus. 2018 Oct 08; 1-9. PMID: 29558286.
    View in: PubMed
  4. Kelly JF. Commentary on Tonigan et al. (2018): Clarifying the evidence for the clinical and public health utility of Alcoholics Anonymous for dual-diagnosis patients. Addiction. 2018 Nov; 113(11):1982-1983. PMID: 30105782.
    View in: PubMed
  5. Kelly JF, Abry AW, Milligan CM, Bergman BG, Hoeppner BB. On being "in recovery": A national study of prevalence and correlates of adopting or not adopting a recovery identity among individuals resolving drug and alcohol problems. Psychol Addict Behav. 2018 Sep; 32(6):595-604. PMID: 30070538.
    View in: PubMed
  6. Kelly JF. E. M. Jellinek's Disease Concept of Alcoholism. Addiction. 2018 Jul 31. PMID: 30064157.
    View in: PubMed
  7. Bergman BG, Claire Greene M, Hoeppner BB, Kelly JF. Expanding the reach of alcohol and other drug services: Prevalence and correlates of US adult engagement with online technology to address substance problems. Addict Behav. 2018 Dec; 87:74-81. PMID: 29960132.
    View in: PubMed
  8. Yule AM, Carrellas NW, Fitzgerald M, McKowen JW, Nargiso JE, Bergman BG, Kelly JF, Wilens TE. Risk Factors for Overdose in Treatment-Seeking Youth With Substance Use Disorders. J Clin Psychiatry. 2018 May/Jun; 79(3). PMID: 29701935.
    View in: PubMed
  9. Kelly JF, Bergman BG, Fallah-Sohy N. MECHANISMS OF BEHAVIOR CHANGE IN 12-STEP APPROACHES TO RECOVERY IN YOUNG ADULTS. Curr Addict Rep. 2018 Jun; 5(2):134-145. PMID: 30416931.
    View in: PubMed
  10. Kelly JF, Greene MC, Bergman BG. Beyond Abstinence: Changes in Indices of Quality of Life with Time in Recovery in a Nationally Representative Sample of U.S. Adults. Alcohol Clin Exp Res. 2018 Apr; 42(4):770-780. PMID: 29473966.
    View in: PubMed
  11. Evins AE, Kelly JF. A Call to Action for Treatment of Comorbid Tobacco and Alcohol Dependence. JAMA Psychiatry. 2018 Feb 01; 75(2):121-122. PMID: 29261821.
    View in: PubMed
  12. Kelly JF, Greene MC, Bergman BG. Is recovery from cannabis use problems different from alcohol and other drugs? Results from a national probability-based sample of the United States adult population. Int J Drug Policy. 2018 03; 53:55-64. PMID: 29287223.
    View in: PubMed
  13. Yule AM, Kelly JF. Recovery high schools may be a key component of youth recovery support services. Am J Drug Alcohol Abuse. 2018; 44(2):141-142. PMID: 29048934.
    View in: PubMed
  14. Kelly JF, Bergman B, Hoeppner BB, Vilsaint C, White WL. Prevalence and pathways of recovery from drug and alcohol problems in the United States population: Implications for practice, research, and policy. Drug Alcohol Depend. 2017 12 01; 181:162-169. PMID: 29055821.
    View in: PubMed
  15. Hoeppner BB, Hoeppner SS, Kelly L, Schick M, Kelly JF. Smiling Instead of Smoking: Development of a Positive Psychology Smoking Cessation Smartphone App for Non-daily Smokers. Int J Behav Med. 2017 10; 24(5):683-693. PMID: 28197846.
    View in: PubMed
  16. Hoeppner BB, Schick MR, Kelly LM, Hoeppner SS, Bergman B, Kelly JF. There is an app for that - Or is there? A content analysis of publicly available smartphone apps for managing alcohol use. J Subst Abuse Treat. 2017 11; 82:67-73. PMID: 29021117.
    View in: PubMed
  17. Kelly JF, Kaminer Y, Kahler CW, Hoeppner B, Yeterian J, Cristello JV, Timko C. A pilot randomized clinical trial testing integrated 12-Step facilitation (iTSF) treatment for adolescent substance use disorder. Addiction. 2017 Dec; 112(12):2155-2166. PMID: 28742932.
    View in: PubMed
  18. Vilsaint CL, Kelly JF, Bergman BG, Groshkova T, Best D, White W. Development and validation of a Brief Assessment of Recovery Capital (BARC-10) for alcohol and drug use disorder. Drug Alcohol Depend. 2017 08 01; 177:71-76. PMID: 28578224.
    View in: PubMed
  19. Eddie D, Kelly JF. How many or how much? Testing the relative influence of the number of social network risks versus the amount of time exposed to social network risks on post-treatment substance use. Drug Alcohol Depend. 2017 06 01; 175:246-253. PMID: 28460232.
    View in: PubMed
  20. Kelly JF. Are societies paying unnecessarily for an otherwise free lunch? Final musings on the research on Alcoholics Anonymous and its mechanisms of behavior change. Addiction. 2017 Jun; 112(6):943-945. PMID: 28390078.
    View in: PubMed
  21. Schlussel AT, Wiseman JT, Kelly JF, Davids JS, Maykel JA, Sturrock PR, Sweeney WB, Alavi K. Location is everything: The role of splenic flexure mobilization during colon resection for diverticulitis. Int J Surg. 2017 Apr; 40:124-129. PMID: 28259692.
    View in: PubMed
  22. Kelly JF, Fallah-Sohy N, Cristello J, Bergman B. Coping with the enduring unpredictability of opioid addiction: An investigation of a novel family-focused peer-support organization. J Subst Abuse Treat. 2017 06; 77:193-200. PMID: 28222927.
    View in: PubMed
  23. Bergman BG, Kelly NW, Hoeppner BB, Vilsaint CL, Kelly JF. Digital recovery management: Characterizing recovery-specific social network site participation and perceived benefit. Psychol Addict Behav. 2017 06; 31(4):506-512. PMID: 28206780.
    View in: PubMed
  24. Kelly JF. Tens of millions successfully in long-term recovery-let us find out how they did it. Addiction. 2017 May; 112(5):762-763. PMID: 28054421.
    View in: PubMed
  25. Davis JP, Bergman BG, Smith DC, Kelly JF. Testing a Matching Hypothesis for Emerging Adults in Project MATCH: During-Treatment and One-Year Outcomes. J Stud Alcohol Drugs. 2017 01; 78(1):140-145. PMID: 27936374.
    View in: PubMed
  26. Kelly JF. Is Alcoholics Anonymous religious, spiritual, neither? Findings from 25 years of mechanisms of behavior change research. Addiction. 2017 Jun; 112(6):929-936. PMID: 27718303.
    View in: PubMed
  27. Marcovitz D, Cristello JV, Kelly JF. Alcoholics Anonymous and other mutual help organizations: Impact of a 45-minute didactic for primary care and categorical internal medicine residents. Subst Abus. 2017 Apr-Jun; 38(2):183-190. PMID: 27439353.
    View in: PubMed
  28. Kelly JF, Yeterian JD, Cristello JV, Kaminer Y, Kahler CW, Timko C. Developing and Testing Twelve-Step Facilitation for Adolescents with Substance Use Disorder: Manual Development and Preliminary Outcomes. Subst Abuse. 2016; 10:55-64. PMID: 27429548; PMCID: PMC4941867.
  29. Beck AK, Baker A, Kelly PJ, Deane FP, Shakeshaft A, Hunt D, Forbes E, Kelly JF. Protocol for a systematic review of evaluation research for adults who have participated in the 'SMART recovery' mutual support programme. BMJ Open. 2016 05 23; 6(5):e009934. PMID: 27217279; PMCID: PMC4885378.
  30. Kelly JF, Greene MC, Bergman BG. Recovery benefits of the "therapeutic alliance" among 12-step mutual-help organization attendees and their sponsors. Drug Alcohol Depend. 2016 May 01; 162:64-71. PMID: 26961963.
    View in: PubMed
  31. Kelly JF, Wakeman SE, Saitz R. The Reply. Am J Med. 2015 Jul; 128(7):e31. PMID: 26092077.
    View in: PubMed
  32. Kelly JF, Greene MC, Bergman B, Hoeppner BB, Slaymaker V. The Sponsor Alliance Inventory: Assessing the Therapeutic Bond Between 12-Step Attendees and Their Sponsors. Alcohol Alcohol. 2016 Jan; 51(1):32-9. PMID: 26113488; PMCID: PMC4804117 [Available on 01/01/17].
  33. Hoeppner BB, Hoeppner SS, Seaboyer L, Schick MR, Wu GW, Bergman BG, Kelly JF. How Smart are Smartphone Apps for Smoking Cessation? A Content Analysis. Nicotine Tob Res. 2016 May; 18(5):1025-31. PMID: 26045249.
    View in: PubMed
  34. Bergman BG, Hoeppner BB, Nelson LM, Slaymaker V, Kelly JF. The effects of continuing care on emerging adult outcomes following residential addiction treatment. Drug Alcohol Depend. 2015 Aug 01; 153:207-14. PMID: 26116368; PMCID: PMC4510025.
  35. Kelly JF, Greene MC, Bergman BG. Do Drug-Dependent Patients Attending Alcoholics Anonymous Rather than Narcotics Anonymous Do As Well? A Prospective, Lagged, Matching Analysis. Alcohol Alcohol. 2014 Nov; 49(6):645-53. PMID: 25294352; PMCID: PMC4849344.
  36. Schuman-Olivier Z, Claire Greene M, Bergman BG, Kelly JF. Is residential treatment effective for opioid use disorders? A longitudinal comparison of treatment outcomes among opioid dependent, opioid misusing, and non-opioid using emerging adults with substance use disorder. Drug Alcohol Depend. 2014 Nov 01; 144:178-85. PMID: 25267606.
    View in: PubMed
  37. Yeterian JD, Bursik K, Kelly JF. Religiosity as a Predictor of Adolescents' Substance Use Disorder Treatment Outcomes. Subst Abus. 2015; 36(4):453-61. PMID: 25222569; PMCID: PMC4362954 [Available on 10/01/16].
  38. Kelly JF, Wakeman SE, Saitz R. Stop talking 'dirty': clinicians, language, and quality of care for the leading cause of preventable death in the United States. Am J Med. 2015 Jan; 128(1):8-9. PMID: 25193273.
    View in: PubMed
  39. Greene MC, Kelly JF. The prevalence of cannabis withdrawal and its influence on adolescents' treatment response and outcomes: a 12-month prospective investigation. J Addict Med. 2014 Sep-Oct; 8(5):359-67. PMID: 25100311; PMCID: PMC4176951.
  40. Hoeppner BB, Hoeppner SS, Kelly JF. Do young people benefit from AA as much, and in the same ways, as adult aged 30+? A moderated multiple mediation analysis. Drug Alcohol Depend. 2014 Oct 01; 143:181-8. PMID: 25150401.
    View in: PubMed
  41. Kelly JF, Stout RL, Greene MC, Slaymaker V. Young adults, social networks, and addiction recovery: post treatment changes in social ties and their role as a mediator of 12-step participation. PLoS One. 2014; 9(6):e100121. PMID: 24945357; PMCID: PMC4063778.
  42. Labbe AK, Slaymaker V, Kelly JF. Toward enhancing 12-step facilitation among young people: a systematic qualitative investigation of young adults' 12-step experiences. Subst Abus. 2014; 35(4):399-407. PMID: 25102256; PMCID: PMC4268407.
  43. Bergman BG, Greene MC, Slaymaker V, Hoeppner BB, Kelly JF. Young adults with co-occurring disorders: substance use disorder treatment response and outcomes. J Subst Abuse Treat. 2014 Apr; 46(4):420-8. PMID: 24484710; PMCID: PMC3968943.
  44. Kelly JF, Greene MC. Where there’s a will there’s a way: a longitudinal investigation of the interplay between recovery motivation and self-efficacy in predicting treatment outcome. Psychol Addict Behav. 2014 Sep; 28(3):928-34. PMID: 24274437; PMCID: PMC4225143.
  45. Bergman BG, Greene MC, Hoeppner BB, Slaymaker V, Kelly JF. Psychiatric comorbidity and 12-step participation: a longitudinal investigation of treated young adults. Alcohol Clin Exp Res. 2014 Feb; 38(2):501-10. PMID: 24033550; PMCID: PMC3946781.
  46. Kelly JF, Greene MC. The Twelve Promises of Alcoholics Anonymous: psychometric measure validation and mediational testing as a 12-step specific mechanism of behavior change. Drug Alcohol Depend. 2013 Dec 01; 133(2):633-40. PMID: 24004905; PMCID: PMC3818412.
  47. Kelly JF, Greene MC. Beyond motivation: Initial validation of the commitment to sobriety scale. J Subst Abuse Treat. 2014 Feb; 46(2):257-63. PMID: 23953168; PMCID: PMC3840075.
  48. Labbe AK, Greene C, Bergman BG, Hoeppner B, Kelly JF. The importance of age composition of 12-step meetings as a moderating factor in the relation between young adults' 12-step participation and abstinence. Drug Alcohol Depend. 2013 Dec 01; 133(2):541-7. PMID: 23938074; PMCID: PMC3818368.
  49. Kelly JF. Alcoholics Anonymous science update: introduction to the special issue. Subst Abus. 2013; 34(1):1-3. PMID: 23327498.
    View in: PubMed
  50. Yeterian JD, Greene MC, Bergman BG, Kelly JF. Does Mandated Treatment Benefit Youth? A Prospective Investigation of Adolescent Justice System Involvement, Treatment Motivation, and Substance Use Outcomes. Alcohol Treat Q. 2013 Jan 01; 31(4):431-449. PMID: 24159252.
    View in: PubMed
  51. Pagano ME, Kelly JF, Scur MD, Ionescu RA, Stout RL, Post SG. Assessing youth participation in AA-related helping: validity of the Service to Others in Sobriety (SOS) questionnaire in an adolescent sample. Am J Addict. 2013 Jan; 22(1):60-6. PMID: 23398228; PMCID: PMC3645471.
  52. Pagano ME, White WL, Kelly JF, Stout RL, Tonigan JS. The 10-year course of Alcoholics Anonymous participation and long-term outcomes: a follow-up study of outpatient subjects in Project MATCH. Subst Abus. 2013; 34(1):51-9. PMID: 23327504; PMCID: PMC3558837.
  53. Dow SJ, Kelly JF. Listening to youth: Adolescents' reasons for substance use as a unique predictor of treatment response and outcome. Psychol Addict Behav. 2013 Dec; 27(4):1122-31. PMID: 23276316; PMCID: PMC3864177.
  54. Kelly JF, Hoeppner BB. Does Alcoholics Anonymous work differently for men and women? A moderated multiple-mediation analysis in a large clinical sample. Drug Alcohol Depend. 2013 Jun 01; 130(1-3):186-93. PMID: 23206376; PMCID: PMC3596430.
  55. Kelly JF, Stout RL, Slaymaker V. Emerging adults' treatment outcomes in relation to 12-step mutual-help attendance and active involvement. Drug Alcohol Depend. 2013 Apr 01; 129(1-2):151-7. PMID: 23122600; PMCID: PMC3566342.
  56. Yeterian JD, Dow SJ, Kelly JF. Ensuring Retention in Longitudinal Studies: A Practical Evaluation of an Intensive Follow-up Protocol and Suggested Adaptations. Int J Soc Res Methodol. 2012 Sep 01; 15(5). PMID: 24260012.
    View in: PubMed
  57. Stout RL, Kelly JF, Magill M, Pagano ME. Association between social influences and drinking outcomes across three years. J Stud Alcohol Drugs. 2012 May; 73(3):489-97. PMID: 22456254; PMCID: PMC3316719.
  58. Kelly JF, Urbanoski K. Youth recovery contexts: the incremental effects of 12-step attendance and involvement on adolescent outpatient outcomes. Alcohol Clin Exp Res. 2012 Jul; 36(7):1219-29. PMID: 22509904; PMCID: PMC3394872.
  59. Greenfield BL, Venner KL, Kelly JF, Slaymaker V, Bryan AD. The impact of depression on abstinence self-efficacy and substance use outcomes among emerging adults in residential treatment. Psychol Addict Behav. 2012 Jun; 26(2):246-54. PMID: 22288980; PMCID: PMC3575193.
  60. Urbanoski KA, Kelly JF, Hoeppner BB, Slaymaker V. The role of therapeutic alliance in substance use disorder treatment for young adults. J Subst Abuse Treat. 2012 Oct; 43(3):344-51. PMID: 22285833; PMCID: PMC3345301.
  61. Kelly JF, Yeterian JD. Empirical awakening: the new science on mutual help and implications for cost containment under health care reform. Subst Abus. 2012; 33(2):85-91. PMID: 22489579.
    View in: PubMed
  62. Urbanoski KA, Kelly JF. Understanding genetic risk for substance use and addiction: a guide for non-geneticists. Clin Psychol Rev. 2012 Feb; 32(1):60-70. PMID: 22155620.
    View in: PubMed
  63. Kelly JF, Pagano ME, Stout RL, Johnson SM. Influence of religiosity on 12-step participation and treatment response among substance-dependent adolescents. J Stud Alcohol Drugs. 2011 Nov; 72(6):1000-11. PMID: 22051214; PMCID: PMC3211954.
  64. Kelly JF, Urbanoski KA, Hoeppner BB, Slaymaker V. "Ready, willing, and (not) able" to change: young adults' response to residential treatment. Drug Alcohol Depend. 2012 Mar 01; 121(3):224-30. PMID: 21955361; PMCID: PMC3258469.
  65. Kelly JF, Hoeppner B, Stout RL, Pagano M. Determining the relative importance of the mechanisms of behavior change within Alcoholics Anonymous: a multiple mediator analysis. Addiction. 2012 Feb; 107(2):289-99. PMID: 21917054; PMCID: PMC3242865.
  66. Klein AA, Slaymaker VJ, Kelly JF. The 12 Step Affiliation and Practices Scale: development and initial validation of a measure assessing 12 step affiliation. Addict Behav. 2011 Nov; 36(11):1045-51. PMID: 21764222; PMCID: PMC3800557.
  67. Hoeppner BB, Kelly JF, Urbanoski KA, Slaymaker V. Comparative utility of a single-item versus multiple-item measure of self-efficacy in predicting relapse among young adults. J Subst Abuse Treat. 2011 Oct; 41(3):305-12. PMID: 21700411; PMCID: PMC3315352.
  68. Kelly JF, Hoeppner BB, Urbanoski KA, Slaymaker V. Predicting relapse among young adults: psychometric validation of the Advanced WArning of RElapse (AWARE) scale. Addict Behav. 2011 Oct; 36(10):987-93. PMID: 21700396; PMCID: PMC3135308.
  69. Kelly JF, Dow SJ, Yeterian JD, Myers M. How safe are adolescents at Alcoholics Anonymous and Narcotics Anonymous meetings? A prospective investigation with outpatient youth. J Subst Abuse Treat. 2011 Jun; 40(4):419-25. PMID: 21353446; PMCID: PMC3081965.
  70. Kelly JF, Yeterian JD. The role of mutual-help groups in extending the framework of treatment. Alcohol Res Health. 2011; 33(4):350-5. PMID: 23580019.
    View in: PubMed
  71. Amiaz R, Pope HG, Mahne T, Kelly JF, Brennan BP, Kanayama G, Weiser M, Hudson JI, Seidman SN. Testosterone gel replacement improves sexual function in depressed men taking serotonergic antidepressants: a randomized, placebo-controlled clinical trial. J Sex Marital Ther. 2011; 37(4):243-54. PMID: 21707327.
    View in: PubMed
  72. Kelly JF, Urbanoski KA, Hoeppner BB, Slaymaker V. Facilitating comprehensive assessment of 12-step experiences: A Multidimensional Measure of Mutual-Help Activity. Alcohol Treat Q. 2011 Jan 01; 29(3):181-203. PMID: 22081741.
    View in: PubMed
  73. Kelly JF, Stout RL, Magill M, Tonigan JS, Pagano ME. Spirituality in recovery: a lagged mediational analysis of alcoholics anonymous' principal theoretical mechanism of behavior change. Alcohol Clin Exp Res. 2011 Mar; 35(3):454-63. PMID: 21158876; PMCID: PMC3117904.
  74. Krentzman AR, Robinson EA, Moore BC, Kelly JF, Laudet AB, White WL, Zemore SE, Kurtz E, Strobbe S. How Alcoholics Anonymous (AA) and Narcotics Anonymous (NA) Work: Cross-Disciplinary Perspectives. Alcohol Treat Q. 2010 Dec; 29(1):75-84. PMID: 21785524.
    View in: PubMed
  75. Kelly JF, Stout RL, Magill M, Tonigan JS. The role of Alcoholics Anonymous in mobilizing adaptive social network changes: a prospective lagged mediational analysis. Drug Alcohol Depend. 2011 Apr 01; 114(2-3):119-26. PMID: 21035276; PMCID: PMC3062700.
  76. Kelly JF, Stout RL, Tonigan JS, Magill M, Pagano ME. Negative affect, relapse, and Alcoholics Anonymous (AA): does AA work by reducing anger? J Stud Alcohol Drugs. 2010 May; 71(3):434-44. PMID: 20409438; PMCID: PMC2859791.
  77. Pope HG, Amiaz R, Brennan BP, Orr G, Weiser M, Kelly JF, Kanayama G, Siegel A, Hudson JI, Seidman SN. Parallel-group placebo-controlled trial of testosterone gel in men with major depressive disorder displaying an incomplete response to standard antidepressant treatment. J Clin Psychopharmacol. 2010 Apr; 30(2):126-34. PMID: 20520285.
    View in: PubMed
  78. Kelly JF, Dow SJ, Yeterian JD, Kahler CW. Can 12-step group participation strengthen and extend the benefits of adolescent addiction treatment? A prospective analysis. Drug Alcohol Depend. 2010 Jul 01; 110(1-2):117-25. PMID: 20338698; PMCID: PMC2885484.
  79. Kelly JF, Stout RL, Magill M, Tonigan JS, Pagano ME. Mechanisms of behavior change in alcoholics anonymous: does Alcoholics Anonymous lead to better alcohol use outcomes by reducing depression symptoms? Addiction. 2010 Apr; 105(4):626-36. PMID: 20102345; PMCID: PMC2857524.
  80. Kelly JF, Westerhoff CM. Does it matter how we refer to individuals with substance-related conditions? A randomized study of two commonly used terms. Int J Drug Policy. 2010 May; 21(3):202-7. PMID: 20005692.
    View in: PubMed
  81. Kelly JF, Magill M, Slaymaker V, Kahler C. Psychometric validation of the Leeds Dependence Questionnaire (LDQ) in a young adult clinical sample. Addict Behav. 2010 Apr; 35(4):331-6. PMID: 20004062; PMCID: PMC3773982.
  82. Kelly JF, Brown SA, Abrantes A, Kahler CW, Myers M. Social recovery model: an 8-year investigation of adolescent 12-step group involvement following inpatient treatment. Alcohol Clin Exp Res. 2008 Aug; 32(8):1468-78. PMID: 18557829; PMCID: PMC3759822.
  83. Kelly JF, McCrady BS. Twelve-step facilitation in non-specialty settings. Recent Dev Alcohol. 2008; 18:321-46. PMID: 19115777.
    View in: PubMed
  84. Kelly JF, Myers MG, Rodolico J. What do adolescents exposed to Alcoholics Anonymous think about 12-step groups? Subst Abus. 2008; 29(2):53-62. PMID: 19042324; PMCID: PMC3811164.
  85. Kelly JF, Yeterian J, Myers MG. TREATMENT STAFF REFERRALS, PARTICIPATION EXPECTATIONS, AND PERCEIVED BENEFITS AND BARRIERS TO ADOLESCENT INVOLVEMENT IN 12-STEP GROUPS. Alcohol Treat Q. 2008; 26(4). PMID: 24307753.
    View in: PubMed
  86. Kelly JF, Myers MG. Adolescents' participation in Alcoholics Anonymous and Narcotics Anonymous: review, implications and future directions. J Psychoactive Drugs. 2007 Sep; 39(3):259-69. PMID: 18159779.
    View in: PubMed
  87. Barr RS, Culhane MA, Jubelt LE, Mufti RS, Dyer MA, Weiss AP, Deckersbach T, Kelly JF, Freudenreich O, Goff DC, Evins AE. The effects of transdermal nicotine on cognition in nonsmokers with schizophrenia and nonpsychiatric controls. Neuropsychopharmacology. 2008 Feb; 33(3):480-90. PMID: 17443126.
    View in: PubMed
  88. Kelly JF, Stout R, Zywiak W, Schneider R. A 3-year study of addiction mutual-help group participation following intensive outpatient treatment. Alcohol Clin Exp Res. 2006 Aug; 30(8):1381-92. PMID: 16899041.
    View in: PubMed
  89. Kahler CW, Kelly JF, Strong DR, Stuart GL, Brown RA. Development and initial validation of a 12-step participation expectancies questionnaire. J Stud Alcohol. 2006 Jul; 67(4):538-42. PMID: 16736073.
    View in: PubMed
  90. Myers MG, Kelly JF. Cigarette smoking among adolescents with alcohol and other drug use problems. Alcohol Res Health. 2006; 29(3):221-7. PMID: 17373413; PMCID: PMC1931414.
  91. Tracy SW, Kelly JF, Moos RH. The influence of partner status, relationship quality and relationship stability on outcomes following intensive substance-use disorder treatment. J Stud Alcohol. 2005 Jul; 66(4):497-505. PMID: 16240557.
    View in: PubMed
  92. Kelly JF, Finney JW, Moos R. Substance use disorder patients who are mandated to treatment: characteristics, treatment process, and 1- and 5-year outcomes. J Subst Abuse Treat. 2005 Apr; 28(3):213-23. PMID: 15857721.
    View in: PubMed
  93. Kelly JF, Myers MG, Brown SA. The Effects of Age Composition of 12-Step Groups on Adolescent 12-Step Participation and Substance Use Outcome. J Child Adolesc Subst Abuse. 2005; 15(1):63-72. PMID: 18080000.
    View in: PubMed
  94. Kelly JF. Self-help for substance-use disorders: history, effectiveness, knowledge gaps, and research opportunities. Clin Psychol Rev. 2003 Oct; 23(5):639-63. PMID: 12971904.
    View in: PubMed
  95. Kelly JF, Moos R. Dropout from 12-step self-help groups: prevalence, predictors, and counteracting treatment influences. J Subst Abuse Treat. 2003 Apr; 24(3):241-50. PMID: 12810145.
    View in: PubMed
  96. Kelly JF, McKellar JD, Moos R. Major depression in patients with substance use disorders: relationship to 12-Step self-help involvement and substance use outcomes. Addiction. 2003 Apr; 98(4):499-508. PMID: 12653819.
    View in: PubMed
  97. Fernando P, Kelly JF, Balazsi K, Slack RS, Megeney LA. Caspase 3 activity is required for skeletal muscle differentiation. Proc Natl Acad Sci U S A. 2002 Aug 20; 99(17):11025-30. PMID: 12177420; PMCID: PMC123204.
  98. Kelly JF, Myers MG, Brown SA. Do adolescents affiliate with 12-step groups? A multivariate process model of effects. J Stud Alcohol. 2002 May; 63(3):293-304. PMID: 12086130.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Kelly's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (215)
Explore
_
Co-Authors (22)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH/NCATS Clinical and Translational Science Award (CTSA) program, grant number UL1TR001102, and through institutional support from Harvard University, Harvard Medical School, Harvard T.H. Chan School of Public Health, Beth Israel Deaconess Medical Center, Boston Children's Hospital, Brigham and Women's Hospital, Massachusetts General Hospital and the Dana Farber Cancer Institute.